Loading...
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
BACKGROUND: Treatment with tamoxifen or chemotherapy reduces the risk of contralateral breast cancer (CBC). However, it is uncertain how long the protection lasts and whether the protective effect is modified by patient, tumor, or treatment characteristics. METHODS: The population-based WECARE Study...
Na minha lista:
Udgivet i: | Breast Cancer Res |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940926/ https://ncbi.nlm.nih.gov/pubmed/27400983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0726-0 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|